Quantcast

Latest Cystic fibrosis Stories

2014-08-19 12:29:01

New respiratory therapy device uses sound waves at different frequencies to promote Airway Clearance Therapy (ACT). TUSCON, Ariz., Aug. 19, 2014 /PRNewswire/ -- Westmed, Inc., a leader in the design, manufacture and marketing of medical devices used in respiratory therapy and anesthesia, announced today that the U.S. Food and Drug Administration (FDA) has granted it 510(k) clearance to market the company's Vibralung(®) Acoustical Percussor. The device is intended for use by...

2014-08-18 12:27:32

- Recipients will compete for public votes for a chance to win one of two Thriving Undergraduate and Graduate Scholar awards NORTH CHICAGO, Ill., Aug. 18, 2014 /PRNewswire/ -- AbbVie today announced the 40 outstanding students with cystic fibrosis (CF) who will each receive $2,500 to pursue their undergraduate or graduate school education during the 2014-2015 school year through the AbbVie CF Scholarship program. Voting for two of the 40 winners to earn the title of 2014 Thriving...

2014-08-14 23:06:05

Cystic fibrosis continues to be devastating for many people around the world. ChanTest is participating in global efforts to identify solutions – and publishing a new white paper to share these results. Cleveland, OH (PRWEB) August 14, 2014 With over 70,000 people suffering from cystic fibrosis (CF) worldwide, and 30,000 alone in the United States, the world is searching for impactful solutions to address the pain and suffering endured by people living with this debilitating disease....

2014-08-14 23:00:44

The microdevice can provide new insights in disease studies and drug discovery by mimicking the complex multicellular structure and function of human airway tissue. Research Triangle Park, NC (PRWEB) August 14, 2014 Researchers at RTI International, in collaboration with the University of North Carolina at Chapel Hill, have developed a new lung-on-chip microdevice for laboratory studies of respiratory challenges and therapeutics. The microdevice includes multiple vertically stacked...

2014-08-05 08:33:19

SAN FRANCISCO, Aug. 5, 2014 /PRNewswire/ -- Perlstein Lab PBC, a San Francisco-based public benefit corporation whose mission is precision orphan drug discovery, just closed a $2 million seed round. The round was co-led by the clinical-stage orphan drug developer Retrophin, Inc. and the Wilsey family, which is personally affected by an orphan disease. http://photos.prnewswire.com/prnvar/20140805/133384 One in 12 people suffer from an orphan disease, yet 95% of orphan diseases have...

2014-08-01 12:25:54

- AbbVie will donate $10 to Cystic Fibrosis Research, Inc. (CFRI) for every recipe collected between August 1 and September 15, 2014, up to $10,000 NORTH CHICAGO, Ill. and PALO ALTO, Calif., Aug. 1, 2014 /PRNewswire/ -- AbbVie (NYSE: ABBV) and Cystic Fibrosis Research, Inc. (CFRI) today announced a partnership to expand awareness of proper nutritional habits in the cystic fibrosis (CF) community through the CFChef Shares program. CFChef Shares will run from August 1 to September...

2014-07-28 20:24:33

HAYWARD, Calif., July 28, 2014 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH), today announced financial results and operational update for the second quarter ended June 30, 2014. Net loss for the three months ended June 30, 2014 was $7.3 million, compared to $8.3 million for the same period in 2013. The decrease in net loss is a direct result of a decrease in interest expense in the current period. Net loss for the six months ended June 30, 2014 was $15.2 million,...

2014-07-25 10:36:51

UNC The study, led by Martina Gentzsch, PhD, provides evidence that could help drug developers improve compounds aimed at correcting CFTR proteins in cystic fibrosis patients. In lab experiments using tissue samples cultured from cystic fibrosis patients, scientists at the UNC School of Medicine and the UNC Marsico Lung Institute have shown that a new CF drug counteracts the intended beneficial molecular effect of another CF drug. The finding, published today in the journal Science...

2014-07-24 23:12:56

80s cover band Flashback Heart Attack topped last year's performance at the Cystic Fibrosis Foundation annual charity event by breaking out the rock stars Saturday night. The night set record numbers on attendance and net a profit for Pipeline to a Cure and the Cystic Fibrosis Foundation. Huntington Beach, CA (PRWEB) July 24, 2014 The event, called Pipeline to a Cure, took place Saturday July 19, 2014 at the Hyatt Regency in Huntington Beach, Calif. The evening, coming off the buzz...

2014-07-16 23:04:17

ReportsnReports.com adds “OpportunityAnalyzer: Cystic Fibrosis - Opportunity Analysis and Forecasts to 2018 – Event-Driven Update” to its store. The majority of Cystic Fibrosis sales will come from the US, which will represent 60% of the market by 2018. Dallas, TX (PRWEB) July 16, 2014 Researcher estimates the 2012 sales for Cystic Fibrosis to be approximately $1.2 billion across the six markets covered in this forecast: the US, France, Germany, Italy, Spain and the UK. By the end...


Latest Cystic fibrosis Reference Libraries

Cystic Fibrosis
2013-07-19 15:03:45

Cystic fibrosis, also called mucoviscidosis, is an autosomal recessive genetic disorder of the viscous secretions in the body. In turn, it effects the lungs, pancreas, liver, and intestines, as well as all other exocrine glands in the body. The most common genetic mutation that causes CF is a deletion of three nucleotides that results in a loss of phenylalanine, an amino acid at the 508th position on the protein. It should be noted, however, that there are over a thousand other mutations that...

More Articles (1 articles) »
Word of the Day
blee
  • Color; hue; complexion.
This word is Middle English in origin.
Related